Recursion to Participate in Upcoming Investor Conferences

On April 7, 2026 Recursion (Nasdaq: RXRX), a leading clinical-stage TechBio company decoding biology to radically improve lives, reported its participation in the following upcoming investor conferences:

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

25th Annual Needham Virtual Healthcare Conference – Monday, April 13, 2026
Bank of America Health Care Conference 2026 – Tuesday, May 12, 2026

Webcasts may be found in the events section of the Recursion Investor Relations website at ir.recursion.com.

(Press release, Recursion Pharmaceuticals, APR 7, 2026, View Source [SID1234664223])